Journal ArticleDOI
EBUS: Faster, cheaper and most effective in lung cancer staging.
Reads0
Chats0
TLDR
The latest findings regarding the benefits of EBUS are outlined in this review, which is the first to emphasise the impact of the procedure, both on timing and costs of lung cancer staging, as well as on survival.Abstract:
The use of endobronchial ultrasound trans-bronchial needle aspiration (EBUS-TBNA) as the initial diagnostic and staging procedure in patients with suspected, non-metastatic lung cancer has gained substantial support, and is now recommended by numerous guidelines. Whereas considerable attention has been pointed to the reductions in costs achieved by EBUS-TBNA, that has not been the case for some of its more significant benefits, namely the reduction of the diagnostic work-up time and its ability to accurately assess and restage lymph nodes, which were previously stated incorrectly by CT or PET scan. Both these benefits translate into improved outcomes for patients, as delays are reduced, futile surgeries are prevented and curable operations can be performed on patients previously excluded by CT or PET scan. Indeed, the use of EBUS as the initial diagnostic and staging procedure has been proven to significantly increase survival, compared with conventional diagnostic and staging procedures, in a pragmatic, randomised controlled trial (Navani N. et al, 2015). The instalment of EBUS will have the greatest effect on overwhelmed, suboptimally functioning national healthcare systems, by decreasing the number of required diagnostic and staging procedures, therefore reducing both treatment delays and costs. The improved selection of surgical candidates by EBUS will result in improved patient outcomes. The latest findings regarding the benefits of EBUS are outlined in this review, which, to the best of our knowledge, is the first to emphasise the impact of the procedure, both on timing and costs of lung cancer staging, as well as on survival.read more
Citations
More filters
Journal ArticleDOI
Recent Trends of Lung Cancer in Korea.
TL;DR: In this article, the authors reviewed recent trends on the incidence, epidemiology, screening, diagnosis, and treatment of lung cancer in Korea by analyzing data from the national lung cancer registry and recently published studies.
Journal ArticleDOI
Endobronchial ultrasound-guided transbronchial cryo-nodal biopsy: a novel approach for mediastinal lymph node sampling.
Hari Kishan Gonuguntla,Milap Shah,Nitesh Gupta,Sumita Agrawal,Venerino Poletti,Gustavo Cumbo Nacheli +5 more
TL;DR: The feasibility, technical details, and complications of EBUS-guided transbronchial cryo-node biopsy (TBCNB) in four patients with mediastinal adenopathy were described in this paper.
Journal ArticleDOI
Recent advances in diagnostic technologies in lung cancer
TL;DR: This review extensively describes the current available diagnostic tools in lung cancer and suggests that there are increasing diagnostic demands for small peripheral lung lesions.
Journal ArticleDOI
Mediastinal “deep freeze”—transcarinal lymph node cryobiopsy
TL;DR: This work aimed to assess the efficacy and safety of transcarinal EBUS‐guided lymph node cryobiopsy and aims to provide bronchoscopically obtained, larger specimen samples from mediastinal lymph nodes.
Journal ArticleDOI
Image-guided lymph node fine-needle aspiration: the Johns Hopkins Hospital experience.
TL;DR: In this paper, the authors reviewed 1237 image-guided lymph node aspirates from 695 procedures (410 nodes from 360 ultrasound [US]-guided cases, 799 from 309 endobronchial ultrasound [EBUS], 25 from 23 endoscopic ultrasound [EUS], and 3 from 3 computed tomography [CT]).
References
More filters
Journal ArticleDOI
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay,Eva Steliarova-Foucher,Joannie Lortet-Tieulent,Sonia Rosso,Jan Willem Coebergh,Harry Comber,David Forman,Freddie Bray +7 more
TL;DR: Up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe.
Journal ArticleDOI
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
TL;DR: Surgical resection remains the primary and preferred approach to the treatment of stage I and II NSCLC, and mediastinal lymph node sampling at the time of curative intent surgical resection can be performed without increased morbidity.
Journal ArticleDOI
The Eighth Edition Lung Cancer Stage Classification
TL;DR: This paper summarizes the eighth edition of lung cancer stage classification, which is the worldwide standard as of January 1, 2017, based on a large global database, a sophisticated analysis, extensive internal validation as well as multiple assessments confirming generalizability.
Journal ArticleDOI
Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized Trial
Jouke T. Annema,Jan P. van Meerbeeck,Robert C. Rintoul,Christophe Dooms,Ellen Deschepper,Olaf M. Dekkers,Paul De Leyn,Jerry Braun,Nicholas Carroll,Marleen Praet,Frederick de Ryck,Johan Vansteenkiste,Frank Vermassen,Michel I.M. Versteegh,Maud Veselic,Andrew G. Nicholson,Klaus F. Rabe,Kurt G. Tournoy +17 more
TL;DR: Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies.
Journal ArticleDOI
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer
Kazuhiro Yasufuku,Andrew Pierre,Gail Darling,Marc de Perrot,Thomas G. Waddell,Michael R. Johnston,Gilda da Cunha Santos,William B. Geddie,Scott A. Boerner,Lisa W. Le,Shaf Keshavjee +10 more
TL;DR: EBUS-TBNA can replace mediastinoscopy in patients with potentially resectable non-small cell lung cancer and achieve similar results for the mediastinal staging of lung cancer.